Evidence map›Paper›PMID 31506011›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2020

High long-term test-retest reliability for extrastriatal

Nina Karalija, Lars Jonassson, Jarkko Johansson, Goran Papenberg, Alireza Salami, Micael Andersson, Katrine Riklund, Lars Nyberg, Carl-Johan Boraxbekk

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Amphetamine-induced dopamine release in rat: Whole-brain spatiotemporal analysis with [Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Relative Strengths of Three Linearizations of Receptor Availability: Saturation, Inhibition, and Occupancy Plots.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Nina KaralijaDepartment of Radiation Sciences, Umeå University, Umeå, Sweden.ORCID 0000-0002-8603-9453
Lars JonasssonUmeå Center for Functional Brain Imaging (UFBI), Umeå University, Umeå, Sweden.
Jarkko JohanssonDepartment of Radiation Sciences, Umeå University, Umeå, Sweden.
Goran PapenbergAging Research Center, Karolinska Institutet and Stockholm University, Stockholm, Sweden.
Alireza SalamiDepartment of Radiation Sciences, Umeå University, Umeå, Sweden.
Micael AnderssonUmeå Center for Functional Brain Imaging (UFBI), Umeå University, Umeå, Sweden.
Katrine RiklundDepartment of Radiation Sciences, Umeå University, Umeå, Sweden.ORCID 0000-0001-5227-8117
Lars NybergDepartment of Radiation Sciences, Umeå University, Umeå, Sweden.
Carl-Johan BoraxbekkDepartment of Radiation Sciences, Umeå University, Umeå, Sweden.ORCID 0000-0002-4458-6475
Umeå University · SEStockholm University · SECopenhagen University Hospital · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In vivo dopamine D2-receptor availability is frequently assessed with

Indexed as

AdultAgedBenzamidesCarbon RadioisotopesCerebral CortexCorpus StriatumDopamine AgonistsFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedPositron-Emission TomographyPyrrolidinesRacloprideRadiopharmaceuticalsBenzamidesCarbon RadioisotopesDopamine AgonistsN-((1-allyl-2-pyrrolidinyl)methyl)-5-(3-fluoropropyl)-2,3-dimethoxybenzamidePyrrolidinesRacloprideRadiopharmaceuticalsReceptors, Dopamine D211C-raclopridebinding potentialextrastriatalpositron emission tomographyreliability

Identifiers

PMID31506011
PMCPMC7446562
OpenAlexW2972420026

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.